When the FBI is ready to make you a snitch, they pounce quickly. And it just may be worse than prison.» Read More
Prosecutors have issued subpoenas in an investigation into whether congressional staff tipped stock traders to a change in health-care policy. The WSJ reports.
One of the most breathtakingly incompetent ideas I've ever heard is the idea of legalizing all insider trading, says attorney Andrew Stoltmann.
A new study says insider trading may be involved in 25 percent of public company deals. That has some arguing that it should be legalized.
A New York Times article reveals a study of hundreds of deals involving public companies from 1996 through the end of 2012. 1 in 4 of those deals was surrounded by some kind of suspicious activity. CNBC contributor Carol Roth, and civil securities attorney Andrew Stoltmann, weigh in.
CNBC included Motif Investing in its "Disruptor 50" list this year. Its co-founder & CEO Hardeep Walia, says shale, China internet and transportation are current motifs his company is eyeing.
Discussing current market trends, and strategies to picking stocks, with John Buckingham, AFAM Capital CIO, and Hardeep Walia, Motif Investing co-founder & CEO.
An article in the New York Times reveals a study which looked at hundreds of deals involving public companies from 1996 through the end of 2012. 1 in 4 of those deals was surrounded by some kind of suspicious activity. Katherine Mangu-Ward, Reason Magazine, and former SEC Commissioner Harvey Pitt, discuss.
A new study reveals that insider trading is more rampant than previously thought; Carol Roth says it's time to legalize it.
FMHR trader Pete Najarian provides perspective on a new study which reveals suspicious profitable trades surrounding public company deals. Andrew Ross Sorkin, weighs in.
CNBC's Andrew Ross Sorkin provides insight to a new study which reveals just how prevalent insider trading is on Wall Street.
How do you know when you’re being played in this market? This ex-Galleon trader offers insight on how you know — and how you play them right back.
The "Squawk Box" news team discusses the results of an exhaustive study that shows a growing number of insider trades.
The U.S. Supreme Court on Monday left intact the insider trading conviction of Galleon Group hedge fund founder Raj Rajaratnam.
Galleon Group's Raj Rajaratnam is currently serving 11 years for insider trading, reports CNBC's Scott Cohn with the latest details on the U.S. Supreme Court decision.
The golfer did not trade in Clorox just as Carl Icahn was mounting an unsolicited takeover bid, say four people briefed on the matter. The NYT reports.
A former board member at Goldman Sachs must report to prison as scheduled next week for his conviction on insider trading charges.
In a loss for the SEC, a federal jury found the former CEO of sTec not liable for trading on inside information ahead of a secondary stock offering.
James Stewart, The New York Times, discusses his column on the insider trading inquiry of pro golfer Phil Mickelson and investor Carl Icahn. Stewart delves into the psychology of why "famous rich" people get involved with insider trading.
Here's why Carl Icahn won’t likely be joining the Mount Rushmore of insider trading, says ex-Galleon trader Turney Duff.
Discussing if Phil Mickelson's sponsorships are at risk following an insider trading investigation involving the golfer and billionaire Carl Icahn, with Bill Colvin, Colvin Sports Network, and Moshe Cohen, Columbia Business School.